In vivo and in vitro Evaluation of Cytokine Expression Profiles During Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection.
Ayman MubarakBahauddeen AlrfaeiAbdullah AljurayyanMahfoudh M AlqafilMohamed A FarragMaaweya E HamedBandar AlosaimiFahad AlmajhdiWael AlturaikiPublished in: Journal of inflammation research (2021)
MERS-CoV can decrease IFN levels to interfere with the IFN pathway and enhance the production of regulatory cytokines. Inhibition of the increases in IL-27 and IL-35 may contribute to halting MERS-CoV in the early stage of infection.